A quality agreement allocates quality-related activities between parties. It should complement—not replace—the commercial agreement and applicable legal responsibilities.
What procurement and laboratory teams should review
Assign specification, sampling, testing and release responsibilities
Define records, data access and retention
Set change-notification, deviation and complaint pathways
Address subcontractors, audits and business continuity
Verify the scope behind every compliance term
COA, GMP, DMF, LOA, audit and quality agreement describe different evidence or responsibilities. Their relevance depends on the product, manufacturing stage, jurisdiction and buyer’s intended research or development pathway.
- Ask which legal entity, site, material and operation a claim covers.
- Verify confidential-file reference procedures separately from product release.
- Document outsourced roles, change notification and destination responsibilities.
Questions to resolve before quotation or release
- Who has final release authority?
- Which changes require prior approval versus notification?
- How are out-of-specification results and investigations communicated?
Quality-agreement scope should match the actual supply model; a research catalog order and a regulated CDMO program do not require identical documentation.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.